Prognostic Value of LVI and PNI in Stage III Colon Cancer: A Comprehensive Analysis

This article examines the prognostic significance of lymphovascular invasion (LVI) and perineural invasion (PNI) in stage III colon cancer. The study discovered that LVI and PNI are crucial pathological markers for predicting 3-year disease-free survival (DFS) in patients with stage III colorectal cancer. The presence of LVI and PNI was associated with advanced N stage, suggesting an unfavorable clinical trajectory. Additionally, the study revealed that LVI exhibits superior predictive value for the effectiveness of adjuvant chemotherapy compared to PNI. The presence of both LVI and PNI was linked to the poorest 3-year DFS and overall survival rates. The study proposes that LVI and PNI are correlated with aggressive tumor characteristics, and gaining insight into the underlying mechanisms could facilitate the development of therapeutic approaches to inhibit metastatic spread. The study also suggests that the presence of LVI can serve as a guide for personalized management of adjuvant chemotherapy in stage III colon cancer. However, the study acknowledges limitations, including its retrospective design and a limited patient cohort, necessitating further validation through prospective, multicenter clinical trials with a larger population. Furthermore, the absence of tumor molecular markers in the study limits comprehensive risk stratification. Future research should incorporate these markers for more precise risk assessment.